California State Teachers Retirement System (CalSTRS)
CRSP icon

California State Teachers Retirement System (CalSTRS)’s CRISPR Therapeutics CRSP Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.35M Sell
98,168
-3,064
-3% -$161K ﹤0.01% 1046
2026
Q1 		$4.82M Buy
101,232
+23,109
+30% +$1.22M 0.01% 1040
2025
Q4 		$4.1M Buy
78,123
+3,212
+4% +$192K ﹤0.01% 1027
2025
Q3 		$4.85M Buy
74,911
+4
+0% +$230 0.01% 951
2025
Q2 		$3.64M Buy
74,907
+5,165
+7% +$200K ﹤0.01% 1056
2025
Q1 		$2.37M Hold
69,742
– – ﹤0.01% 1242
2024
Q4 		$2.75M Sell
69,742
-689
-1% -$32.5K ﹤0.01% 1216
2024
Q3 		$3.31M Sell
70,431
-2,472
-3% -$125K ﹤0.01% 1116
2024
Q2 		$3.94M Buy
72,903
+5,002
+7% +$289K ﹤0.01% 994
2024
Q1 		$4.63M Buy
67,901
+710
+1% +$50.8K 0.01% 957
2023
Q4 		$4.21M Buy
67,191
+883
+1% +$48.8K 0.01% 1008
2023
Q3 		$3.01M Buy
66,308
+564
+0.9% +$29.1K ﹤0.01% 1149
2023
Q2 		$3.69M Buy
65,744
+403
+0.6% +$22.9K 0.01% 1134
2023
Q1 		$2.96M Buy
65,341
+860
+1% +$41.8K ﹤0.01% 1258
2022
Q4 		$2.62M Buy
64,481
+1,169
+2% +$62K ﹤0.01% 1319
2022
Q3 		$4.14M Buy
63,312
+566
+0.9% +$41K 0.01% 1014
2022
Q2 		$3.81M Buy
62,746
+10,698
+21% +$629K 0.01% 1108
2022
Q1 		$3.27M Buy
52,048
+462
+0.9% +$29K ﹤0.01% 1312
2021
Q4 		$3.91M Buy
51,586
+1,966
+4% +$172K ﹤0.01% 1313
2021
Q3 		$5.55M Buy
+49,620
New +$6.23M 0.01% 1080

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s CRSP Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its CRISPR Therapeutics (CRSP) stake by 3% in Q2 2026, selling an estimated $161K and leaving 98,168 shares worth $5.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1046.

California State Teachers Retirement System (CalSTRS) first reported a position in CRSP in Q3 2021 and has held it in 20 quarters since. The position peaked at $5.55M in Q3 2021. 524 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 98,168 shares of CRISPR Therapeutics worth $5.35M as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) sold 3,064 CRISPR Therapeutics shares in Q2 2026, an estimated $161K.
  • CRISPR Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #1046 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in CRISPR Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s CRISPR Therapeutics position peaked at $5.55M in Q3 2021.
  • 524 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.